HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

D E Neal Selected Research

Neoplasms (Cancer)

11/2014N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.
1/2012Systematic review and economic modelling of the relative clinical benefit and cost-effectiveness of laparoscopic surgery and robotic surgery for removal of the prostate in men with localised prostate cancer.
9/2011Suitability of PSA-detected localised prostate cancers for focal therapy: experience from the ProtecT study.
11/2010Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
1/2007Pathogenesis of prostate cancer and hormone refractory prostate cancer.
2/2006Comprehensive profiling and localisation of the matrix metalloproteinases in urothelial carcinoma.
3/2004Long-term follow-up of Anglian Germ Cell Cancer Group surveillance versus patients with Stage 1 nonseminoma treated with adjuvant chemotherapy.
3/2003An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer.
1/2003Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy.
12/2001Combined p21WAF1/CIP1 and p53 overexpression predict improved survival in muscle-invasive bladder cancer treated by radical radiotherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


D E Neal Research Topics

Disease

32Prostatic Neoplasms (Prostate Cancer)
03/2021 - 08/2000
14Neoplasms (Cancer)
11/2014 - 08/2000
6Urinary Bladder Neoplasms (Bladder Cancer)
01/2017 - 04/2001
4Carcinoma (Carcinomatosis)
08/2008 - 08/2000
4Transitional Cell Carcinoma
06/2003 - 01/2001
3Neoplasm Metastasis (Metastasis)
04/2015 - 02/2006
3Urinary Retention
07/2001 - 07/2000
2Margins of Excision
12/2014 - 01/2012
2Carcinogenesis
01/2009 - 08/2001
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2004 - 12/2000
1Nocturia
10/2016
1Obesity
03/2011
1Inflammation (Inflammations)
01/2009
1Adenoma (Adenomas)
01/2009
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
03/2004
1Chronic Disease (Chronic Diseases)
01/2004
1Peripheral Nervous System Diseases (PNS Diseases)
03/2003
1Disease Progression
11/2001
1Fistula
04/2001
1Metaplasia
10/2000
1Adenocarcinoma
08/2000
1Lower Urinary Tract Symptoms
07/2000

Drug/Important Bio-Agent (IBA)

11AndrogensIBA
03/2021 - 08/2000
7Prostate-Specific Antigen (Semenogelase)IBA
04/2015 - 08/2009
4Hormones (Hormone)IBA
01/2007 - 08/2000
3Messenger RNA (mRNA)IBA
09/2015 - 08/2000
3Matrix Metalloproteinases (MMPs)IBA
08/2008 - 11/2001
3Androgen Receptors (Androgen Receptor)IBA
01/2007 - 10/2000
2MicronutrientsIBA
01/2017 - 01/2017
2Membrane Proteins (Integral Membrane Proteins)IBA
11/2014 - 08/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2006 - 12/2000
2Insulin-Like PeptidesIBA
01/2004 - 10/2000
2SteroidsIBA
12/2001 - 08/2000
2Fibroblast Growth Factor 7FDA Link
08/2001 - 12/2000
2NeodymiumIBA
07/2001 - 07/2000
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1ChromatinIBA
12/2014
1isospaglumic acid (NAAGA)IBA
11/2014
1Adenosine Monophosphate (AMP)IBA
11/2014
1Carrier Proteins (Binding Protein)IBA
11/2014
1Biomarkers (Surrogate Marker)IBA
11/2014
1Peptide Hydrolases (Proteases)FDA Link
11/2014
1Transcription Factors (Transcription Factor)IBA
01/2009
1ProstaglandinsIBA
01/2009
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2009
1EndopeptidasesIBA
08/2008
1ZincIBA
08/2008
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
08/2008
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2007
1Phosphotransferases (Kinase)IBA
05/2007
1MitogensIBA
05/2007
1RNA (Ribonucleic Acid)IBA
02/2006
1Histone Deacetylases (Histone Deacetylase)IBA
03/2004
1Thalidomide (Thalomid)FDA Link
03/2003
1Proteins (Proteins, Gene)FDA Link
12/2001
1ParaffinIBA
12/2001
1Cadherins (E-Cadherin)IBA
12/2001
1Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA
11/2001
1Tissue Inhibitor of Metalloproteinase-1IBA
11/2001
1Fibroblast Growth Factor 1 (FGF-1)IBA
08/2001
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2001
1Cyclin D1IBA
01/2001
1EnzymesIBA
12/2000
1ImmunosorbentsIBA
12/2000
1LigandsIBA
10/2000
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2000
1Insulin-Like Growth Factor II (Somatomedin A)IBA
10/2000
1MucinsIBA
10/2000
1miboleroneIBA
08/2000
1Testosterone CongenersIBA
08/2000
1PPAR alphaIBA
08/2000
1Fatty Acids (Saturated Fatty Acids)IBA
08/2000

Therapy/Procedure

8Prostatectomy (Retropubic Prostatectomy)
12/2014 - 10/2000
7Radiotherapy
03/2021 - 04/2001
5Therapeutics
03/2021 - 08/2001
4Conservative Treatment
08/2009 - 07/2000
3Laser Therapy (Surgery, Laser)
07/2001 - 07/2000
2Cystectomy
01/2003 - 04/2001
1Aftercare (After-Treatment)
10/2016
1Conformal Radiotherapy
01/2016
1Castration
12/2014
1Blood Transfusion (Blood Transfusions)
01/2012
1Adjuvant Chemotherapy
03/2004
1Nephroureterectomy
06/2003
1Lasers (Laser)
07/2001